Literature DB >> 33914721

Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.

Richard A Teran, Kelly A Walblay, Elizabeth L Shane, Shannon Xydis, Stephanie Gretsch, Alexandra Gagner, Usha Samala, Hyeree Choi, Christy Zelinski, Stephanie R Black.   

Abstract

Early studies suggest that COVID-19 vaccines protect against severe illness (1); however, postvaccination SARS-CoV-2 infections (i.e., breakthrough infections) can occur because COVID-19 vaccines do not offer 100% protection (2,3). Data evaluating the occurrence of breakthrough infections and impact of vaccination in decreasing transmission in congregate settings are limited. Skilled nursing facility (SNF) residents and staff members have been disproportionately affected by SARS-CoV-2, the virus that causes COVID-19 (4,5), and were prioritized for COVID-19 vaccination (6,7). Starting December 28, 2020, all 78 Chicago-based SNFs began COVID-19 vaccination clinics over several weeks through the federal Pharmacy Partnership for Long-Term Care Program (PPP).† In February 2021, through routine screening, the Chicago Department of Public Health (CDPH) identified a SARS-CoV-2 infection in a SNF resident >14 days after receipt of the second dose of a two-dose COVID-19 vaccination series. SARS-CoV-2 cases, vaccination status, and possible vaccine breakthrough infections were identified by matching facility reports with state case and vaccination registries. Among 627 persons with SARS-CoV-2 infection across 75 SNFs since vaccination clinics began, 22 SARS-CoV-2 infections were identified among 12 residents and 10 staff members across 15 facilities ≥14 days after receiving their second vaccine dose (i.e., breakthrough infections in fully vaccinated persons). Nearly two thirds (14 of 22; 64%) of persons with breakthrough infections were asymptomatic; two residents were hospitalized because of COVID-19, and one died. No facility-associated secondary transmission occurred. Although few SARS-CoV-2 infections in fully vaccinated persons were observed, these cases demonstrate the need for SNFs to follow recommended routine infection prevention and control practices and promote high vaccination coverage among SNF residents and staff members.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33914721     DOI: 10.15585/mmwr.mm7017e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  35 in total

1.  Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.

Authors:  Ralf Duerr; Dacia Dimartino; Christian Marier; Paul Zappile; Guiqing Wang; Jennifer Lighter; Brian Elbel; Andrea B Troxel; Adriana Heguy
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 14.808

2.  COVID-19 outbreak in a long-term care facility in Kelowna, British Columbia after rollout of COVID-19 vaccine in March 2021.

Authors:  Fatemeh Sabet; Barbara Gauthier; Muddassir Siddiqui; Amanda Wilmer; Natalie Prystajecky; Pamela Rydings; Michele Andrews; Sue Pollock
Journal:  Can Commun Dis Rep       Date:  2021-12-09

3.  Emerging Evidence on Effectiveness of COVID-19 Vaccines Among Residents of Long-Term Care Facilities.

Authors:  Maximilian Salcher-Konrad; Siân Smith; Adelina Comas-Herrera
Journal:  J Am Med Dir Assoc       Date:  2021-05-25       Impact factor: 4.669

Review 4.  The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.

Authors:  Sarah P Otto; Troy Day; Julien Arino; Caroline Colijn; Jonathan Dushoff; Michael Li; Samir Mechai; Gary Van Domselaar; Jianhong Wu; David J D Earn; Nicholas H Ogden
Journal:  Curr Biol       Date:  2021-06-23       Impact factor: 10.834

5.  What should define a SARS-CoV-2 "breakthrough" infection?

Authors:  John S Schieffelin; Elizabeth B Norton; Jay K Kolls
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

6.  Early success of COVID-19 vaccines in nursing homes: Will it stick?

Authors:  Joseph G Ouslander; Debra Saliba
Journal:  J Am Geriatr Soc       Date:  2021-06-19       Impact factor: 7.538

7.  Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.

Authors:  Lauren Brinkley-Rubinstein; Meghan Peterson; Rosemarie Martin; Philip Chan; Justin Berk
Journal:  N Engl J Med       Date:  2021-07-07       Impact factor: 91.245

8.  COVID-19 vaccination and frailty in older adults.

Authors:  Liang-Kung Chen
Journal:  Arch Gerontol Geriatr       Date:  2021-07-14       Impact factor: 3.250

9.  Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.

Authors:  Meagan P O'Brien; Eduardo Forleo-Neto; Bret J Musser; Flonza Isa; Kuo-Chen Chan; Neena Sarkar; Katharine J Bar; Ruanne V Barnabas; Dan H Barouch; Myron S Cohen; Christopher B Hurt; Dale R Burwen; Mary A Marovich; Peijie Hou; Ingeborg Heirman; John D Davis; Kenneth C Turner; Divya Ramesh; Adnan Mahmood; Andrea T Hooper; Jennifer D Hamilton; Yunji Kim; Lisa A Purcell; Alina Baum; Christos A Kyratsous; James Krainson; Richard Perez-Perez; Rizwana Mohseni; Bari Kowal; A Thomas DiCioccio; Neil Stahl; Leah Lipsich; Ned Braunstein; Gary Herman; George D Yancopoulos; David M Weinreich
Journal:  medRxiv       Date:  2021-06-17

10.  Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.

Authors:  Pinkus Tober-Lau; Tatjana Schwarz; David Hillus; Jana Spieckermann; Elisa T Helbig; Lena J Lippert; Charlotte Thibeault; Willi Koch; Leon Bergfeld; Daniela Niemeyer; Barbara Mühlemann; Claudia Conrad; Stefanie Kasper; Friederike Münn; Frank Kunitz; Terry C Jones; Norbert Suttorp; Christian Drosten; Leif Erik Sander; Florian Kurth; Victor M Corman
Journal:  Emerg Infect Dis       Date:  2021-06-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.